Net Loss of Venmax Drugs & Pharmaceuticals reported to Rs 0.30 crore in the quarter ended September 2024 as against net loss of Rs 0.03 crore during the previous quarter ended September 2023. Sales reported to Rs 0.17 crore in the quarter ended September 2024. There were no Sales reported during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.170 0 OPM %-176.470 - PBDT-0.30-0.03 -900 PBT-0.30-0.03 -900 NP-0.30-0.03 -900 Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live News

Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 August 2024.Powered by Capital Market - Live News

Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended June 2024 as against Rs 0.02 crore during the previous quarter ended June 2023. Sales reported to Rs 0.10 crore in the quarter ended June 2024. There were no Sales reported during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales0.100 0 OPM %-20.000 - PBDT0.010.02 -50 PBT0.010.02 -50 NP0.010.02 -50 Powered by Capital Market - Live News